These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29071540)

  • 1. Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey.
    Azizi AA; Schouten-van Meeteren AYN
    J Neurooncol; 2018 Jan; 136(1):127-134. PubMed ID: 29071540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.
    Gururangan S; Chi SN; Young Poussaint T; Onar-Thomas A; Gilbertson RJ; Vajapeyam S; Friedman HS; Packer RJ; Rood BN; Boyett JM; Kun LE
    J Clin Oncol; 2010 Jun; 28(18):3069-75. PubMed ID: 20479404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study.
    Gururangan S; Fangusaro J; Poussaint TY; McLendon RE; Onar-Thomas A; Wu S; Packer RJ; Banerjee A; Gilbertson RJ; Fahey F; Vajapeyam S; Jakacki R; Gajjar A; Goldman S; Pollack IF; Friedman HS; Boyett JM; Fouladi M; Kun LE
    Neuro Oncol; 2014 Jan; 16(2):310-7. PubMed ID: 24311632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
    No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
    Moorman B; Barbour M; Huang MA
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
    Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
    Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.
    Salloum R; DeWire M; Lane A; Goldman S; Hummel T; Chow L; Miles L; Sutton M; Stevenson C; Fouladi M; Leach J
    J Neurooncol; 2015 Feb; 121(3):591-8. PubMed ID: 25433556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
    Peyrl A; Azizi A; Czech T; Gruber-Olipitz M; Jones N; Haberler C; Prayer D; Autzinger E; Slavc I
    Pediatr Blood Cancer; 2009 Apr; 52(4):476-80. PubMed ID: 19061223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse.
    Roux C; Revon-Rivière G; Gentet JC; Verschuur A; Scavarda D; Saultier P; Appay R; Padovani L; André N
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e630-e634. PubMed ID: 33235152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optic glioma in children: a retrospective analysis of 101 cases.
    Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
    Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
    Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.
    Zhukova N; Rajagopal R; Lam A; Coleman L; Shipman P; Walwyn T; Williams M; Sullivan M; Campbell M; Bhatia K; Gottardo NG; Hansford JR
    Cancer Med; 2019 Jan; 8(1):40-50. PubMed ID: 30569607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient Hepatotoxicity Induced by Vinblastine in a Young Girl with Chiasmatic Low Grade Glioma.
    Franke NE; Blok GJ; Voll ML; Schouten-van Meeteren AYN
    Curr Drug Saf; 2020; 15(3):231-235. PubMed ID: 32682382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.
    Bouffet E; Jakacki R; Goldman S; Hargrave D; Hawkins C; Shroff M; Hukin J; Bartels U; Foreman N; Kellie S; Hilden J; Etzl M; Wilson B; Stephens D; Tabori U; Baruchel S
    J Clin Oncol; 2012 Apr; 30(12):1358-63. PubMed ID: 22393086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
    Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
    Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem.
    Ronghe M; Hargrave D; Bartels U; Tabori U; Vaidya S; Chandler C; Kulkarni A; Bouffet E
    Pediatr Blood Cancer; 2010 Sep; 55(3):471-7. PubMed ID: 20535831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
    Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
    J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of Bevacizumab Activity, and Maintenance of Efficacy in Retreatment After Subsequent Relapse, in Pediatric Low-grade Glioma.
    Kalra M; Heath JA; Kellie SJ; Dalla Pozza L; Stevens MM; Swamy S; McCowage GB
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e341-6. PubMed ID: 26056795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of carboplatin plus vincristine in an optic pathway glioma.
    Moschovi M; Alexiou GA; Papakonstantopoulou I; Gavra M; Sfakianos G; Prodromou N
    Klin Padiatr; 2010 Nov; 222(6):395-6. PubMed ID: 20806167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.